Latest Reports

The “2024 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success. 

This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs. Additionally, 34 companies are profiled, with discussion of their products, strategic market position, background, and outlook.

Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time.

Market Scope’s “2024 European Five Ophthalmic Market Report” analyzes the ophthalmic market in Western Europe’s five largest economies, discussing important trends and key factors for future success in 11 ophthalmic submarkets. The report includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments. It profiles ophthalmic companies in the five markets, provides analysis of current markets, and offers five-year forecasts of market performance.

Market Scope surveyed ophthalmologists and optometrists in the United States and Western Europe during July and August 2024 to measure patients they were seeing and screening for ocular surface disease; adoption of treatments; and insight into the latest market trends.

Practitioners from most specialties (cataract, refractive, cornea, glaucoma, and comprehensive) who self-registered on Market-Scope.com were invited to participate in an annual sponsored survey on ocular surface disease.

An email invitation was sent on July 26, 2024, and a last call went out on Aug. 23, 2024. We received 149 total complete, unique responses—116 from the US and 33 from WE. All results were calculated based on respondent count; because not all questions were applicable to all providers, the respondent count (n) may vary throughout the survey.

Survey reports are strictly a summary analysis of the reported data, and no additional extrapolation to the overall market was performed. All survey data are de-identified and maintained on a secure server.

The “2024 Premium Cataract Surgery Market Report” is designed to provide insights into the most important premium cataract surgery (PCS) markets in the world. We’ve selected and profiled 13 countries that collectively account for 84 percent of global PCS manufacturer revenue and provided a deep dive into each of these markets. Ranked by 2024 PCS manufacturer revenue, they are: the United States, China, Japan, France, Germany, Brazil, Canada, India, Spain, South Korea, Australia, the UK, and Italy.  

For each of these countries, the report focuses on specific characteristics considered vital to the understanding of the opportunities for companies planning to market premium cataract surgery devices or looking to assess the value of each market. 

The “2024 Retinal Pharmaceuticals Market Report: GA and Other Nonexudative Diseases” analyzes the market for complement inhibitors, gene therapies, antioxidants, sustained-release devices, and other treatments for geographic atrophy, dry AMD, and additional nonexudative retinal diseases. The report discusses important trends, analyzes key factors for future market success, examines disease prevalence, reviews patient economics and reimbursement, and forecasts growth over the next five years. Product demand is forecast in units and dollars, and market shares are analyzed by product category. Additionally, 19 competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

The “2024 Ophthalmic OR Microscopes Market Report” is a specialized supplement, expanding on the OR microscope section of Market Scope’s “2024 Ophthalmic Diagnostic Equipment Market Report.” The report is a leading industry source for information on all aspects of the global ophthalmic OR microscopes market.  

The report covers background information on the devices and groups market estimates into three categories: basic microscope models, standard microscope models, and advanced microscope models. Estimates include unit sales, installed equipment base, average prices, and information about the manufacturers that participate in the market.

The “2024 Single-Use Ophthalmic Surgical Products Market Report” examines global and regional markets for single-use ophthalmic surgical products. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.  The report reviews cataract surgery, the dominant procedure in this market, as well as cataract surgery providers worldwide.  

Market segments profiled include viscoelastics, knives, disposable instruments, balanced salt solutions, procedure packs, drapes, sutures, fluid management devices, eye shields, ocular dyes, capsular tension rings, and cautery pencils. 

Additionally, 25 companies are profiled, with discussion of their products, strategic market position, background, and outlook. 

The “2024 Retinal Pharmaceuticals Market Report: Wet AMD and Other Exudative Diseases” analyzes the market for anti-VEGFs and other drugs for the treatment of exudative retinal diseases. The report discusses important trends, analyzes key factors for future market success, examines the market’s evolution, and forecasts growth over the next five years. Product demand is forecast in units and dollars, and market shares are analyzed by product category. Additionally, 40 competitors are profiled, with discussion of their products, strategic market position, background, and outlook. 

The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.